Résultats de la recherche - 158 results
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
Results Uterine Cervical Neoplasms Abstract: The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that assays ...
Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
specimen handling Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vagina Abstract: The accuracy of high-risk human papillomavirus testing with the Xpert HPV assay on vaginal self-samples was compared ...
Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol
Analysis COVID-19 Delivery of Health Care Humans Markov Chains Models, Economic Neoplasms Pandemics Quality-Adjusted Life Years Abstract: INTRODUCTION: Cancer causes a substantial burden to our society, both ...
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Infections Pilot Projects Point-of-Care Systems Uterine Cervical Neoplasms Abstract: BACKGROUND: Globally, cervical cancer is a major public health problem, with about 604,000 new cases and over 340,000 deaths ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
Female Humans Meta-Analysis as Topic Papillomavirus Infections Sensitivity and Specificity Systematic Reviews as Topic Uterine Cervical Dysplasia Uterine Cervical Neoplasms Abstract: INTRODUCTION: Human ...
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Uterine Cervical Neoplasms Abstract: Download the extract or click on the link to access the full publication. Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues.
POLICY Quality Control Uterine Cervical Neoplasms Abstract: We advise that only clinically validated HPV assays which have fulfilled internationally accepted performance criteria be used for primary ...
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
Bray, Freddie; Salvatore Vaccarella Source: Lancet Glob Health, Volume 11, Issue 2 (2023) Keywords: Female Global Health Humans incidence Malawi Uganda Uterine Cervical Neoplasms World Health Organization ...